SEC Form 4 · accession 0001193125-26-385536
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louise Rodino-Klapac
Officer — President, R&D and Tech Ops
Period of report
Sep 4, 2026
Accepted (ET)
Sep 8, 2026 · 8:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2026 | F | 21,423 | $22.22 | D | 203,900 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.